Study Title
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation With Randomization to Either Single Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue
Protocol ID
HeadStart4
Condition/s
Medulloblastoma
Central Nervous System Embryonal Tumors
Central Nervous System Embryonal Tumors
Diagnosis Stage
Newly diagnosed
Location
NZ
Sponsor
Nationwide Children's Hospital
Collaborators
Children's of Alabama
Links
Trial Status
Closed to Recruitment
Sites
Christchurch Hospital
Starship Hospital
The Children's Hospital at Westmead
Starship Hospital
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 4
Age Eligibility
up to 10 Years
International registry ID's
NCT02875314
| Study Title | HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation With Randomization to Either Single Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue |
|---|---|
| Protocol ID | HeadStart4 |
| Disease (Sub Disease) | Medulloblastoma Central Nervous System Embryonal Tumors |
| Diagnosis Stage | Newly diagnosed |
| Location | NZ |
| Sponsor | Nationwide Children's Hospital |
| Collaborators | Children's of Alabama |
| Links | https://clinicaltrials.gov/ct2/show/NCT02875314 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 01/09/2015 |
| Sites | Christchurch Hospital / Starship Hospital/ The Children's Hospital at Westmead |
| Study Type | Treatment |
| Phase | Phase 4 |
| Age Eligibility | up to 10 Years |
| International registry ID's | NCT02875314 |